MCC
MRNA icon

Malaga Cove Capital’s Moderna MRNA Stock Holding History

Malaga Cove Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,045
Closed -$621K – 160
2023
Q1 		$621K Buy
4,045
+1,519
+60% +$251K 0.31% 94
2022
Q4 		$454K Hold
2,526
– – 0.25% 106
2022
Q3 		$299K Buy
+2,526
New +$383K 0.17% 130

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Malaga Cove Capital's MRNA Position: Q2 2023 in Review

Malaga Cove Capital sold out of Moderna (MRNA) in Q2 2023, closing a stake of 4,045 shares — an estimated $621K sold.

Malaga Cove Capital first reported a position in MRNA in Q3 2022 and held it in 3 quarters. The position peaked at $621K in Q1 2023. 966 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Malaga Cove Capital reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Malaga Cove Capital sold 4,045 Moderna shares in Q2 2023, an estimated $621K.
  • Malaga Cove Capital first reported a position in Moderna in Q3 2022 and held it in 3 quarters.
  • Malaga Cove Capital's Moderna position peaked at $621K in Q1 2023.
  • 966 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Malaga Cove Capital's 13F filing for Q2 2023, filed 2 Aug 2023.